Citadel Advisors’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
5,532,976
+3,427,130
| +163% | +$6.68M | ﹤0.01% | 1322 |
|
|
2025
Q1 | $3.71M | Sell |
2,105,846
-72,116
| -3% | -$127K | ﹤0.01% | 2021 |
|
|
2024
Q4 | $5.79M | Sell |
2,177,962
-580,397
| -21% | -$1.54M | ﹤0.01% | 1686 |
|
|
2024
Q3 | $6.32M | Buy |
2,758,359
+762,142
| +38% | +$1.75M | ﹤0.01% | 1578 |
|
|
2024
Q2 | $5.83M | Sell |
1,996,217
-103,378
| -5% | -$302K | ﹤0.01% | 1571 |
|
|
2024
Q1 | $7.64M | Sell |
2,099,595
-877,707
| -29% | -$3.19M | ﹤0.01% | 1462 |
|
|
2023
Q4 | $4.5M | Buy |
2,977,302
+527,446
| +22% | +$796K | ﹤0.01% | 1724 |
|
|
2023
Q3 | $3.28M | Buy |
2,449,856
+38,175
| +2% | +$51.2K | ﹤0.01% | 1962 |
|
|
2023
Q2 | $4.34M | Sell |
2,411,681
-448,189
| -16% | -$807K | ﹤0.01% | 1810 |
|
|
2023
Q1 | $4.75M | Sell |
2,859,870
-2,455,161
| -46% | -$4.08M | ﹤0.01% | 1858 |
|
|
2022
Q4 | $10.2M | Sell |
5,315,031
-328,714
| -6% | -$631K | ﹤0.01% | 1296 |
|
|
2022
Q3 | $12.6M | Buy |
5,643,745
+21,510
| +0.4% | +$48.2K | ﹤0.01% | 1101 |
|
|
2022
Q2 | $18.2M | Sell |
5,622,235
-362,988
| -6% | -$1.18M | ﹤0.01% | 880 |
|
|
2022
Q1 | $31.5M | Buy |
5,985,223
+480,952
| +9% | +$2.53M | 0.01% | 646 |
|
|
2021
Q4 | $46.8M | Sell |
5,504,271
-141,018
| -2% | -$1.2M | 0.01% | 507 |
|
|
2021
Q3 | $56.1M | Sell |
5,645,289
-756,400
| -12% | -$7.52M | 0.01% | 405 |
|
|
2021
Q2 | $57.9M | Sell |
6,401,689
-184,985
| -3% | -$1.67M | 0.01% | 429 |
|
|
2021
Q1 | $68.8M | Buy |
6,586,674
+4,086,050
| +163% | +$42.7M | 0.02% | 335 |
|
|
2020
Q4 | $29.3M | Buy |
+2,500,624
| New | +$29.3M | 0.01% | 664 |
|